Atlas
Back to RCM
Strategic Advisor·RCM

Christina Reszka

Partner (led 2024 acquisition of patient payments and communications platform RevSpring) at Frazier Healthcare Partners

Seattle, Washington

CR
LinkedIn
Why they matter

General Partner who led Frazier's RevSpring buyout and sits on four healthcare boards spanning RCM, revenue integrity, and patient payments — a working owner's view of the category.

Background

Christina Reszka is a General Partner on the Growth Buyout team at Frazier Healthcare Partners, the Seattle-based healthcare-focused investment firm she joined in October 2019 as a Principal; she was promoted to Partner in January 2022 and to General Partner in March 2026. She spent over a decade at Norwest Equity Partners before Frazier, and earlier worked in investment banking at Craig-Hallum Capital Group and LaSalle Bank. She currently represents Frazier on the boards of RevSpring, Konovo (formerly Apollo Intelligence), Accuity Delivery Systems, and United Derm Partners.

Notable deals

  • 2024
    Led Frazier's acquisition of RevSpring, the patient payments and healthcare communications platform, from GTCR alongside NEA and 22C Capital; quoted in the deal announcement as Partner at Frazier
  • 2022
    Led Frazier's acquisition of Apollo Intelligence, the healthcare and life-science real-time insights platform since rebranded as Konovo, where she now sits on the board
  • 2026
    Promoted to General Partner at Frazier Healthcare Partners, with board representation across Accuity Delivery Systems, Konovo, RevSpring, and United Derm Partners
  • 2026
    Oversaw as RevSpring board member the company's acquisition of TrustCommerce from Waud Capital, its first major integrated-payments add-on under Frazier ownership

Call-prep brief

Background

  • General Partner on Frazier Healthcare Partners' Growth Buyout team, based in Seattle. Joined October 2019 as Principal, made Partner January 2022, General Partner March 2026.
  • Ten-plus years at Norwest Equity Partners beforehand; earlier investment banking at Craig-Hallum Capital Group and LaSalle Bank.

Current focus

  • Boards: RevSpring, Konovo, Accuity Delivery Systems, United Derm Partners — a book concentrated in healthcare RCM, revenue integrity, and provider services.
  • RevSpring is the flagship: bought from GTCR in March 2024 with NEA and 22C Capital, with Frazier Executive in Residence Roger Davis installed as executive chairman.

What she cares about

  • Buy-and-build in fragmented healthcare vendor markets, paired with installing operating talent early (the Davis appointment is the tell).
  • Patient financial engagement as a defensible category — RevSpring took Best in KLAS in both 2025 and 2026 and pushed embedded/agentic AI at HIMSS26.

Recent moves

  • February 2026: RevSpring acquired TrustCommerce from Waud Capital, its first major add-on under Frazier, consolidating integrated payments and reconciliation.

Potential sensitivities

  • She is an owner, not a neutral advisor. Anything adjacent to RevSpring, Accuity, or Konovo is live competitive intelligence; expect guardedness on pricing, churn, and payer mix.
  • Frazier underwrote RevSpring at 2024 marks. Valuation comparisons against current comps may land awkwardly.

Ask her

  1. Post-TrustCommerce, is health-system vendor consolidation in payments actually happening, or are buyers still assembling point solutions?
  2. What did the GTCR-to-Frazier transition surface about RevSpring that diligence did not?
  3. Where does agentic AI genuinely move RCM unit economics, versus where is it still a demo?

Outreach draft

Subject
RevSpring lessons for a patient-payments thesis
Hi Christina, We're doing diligence in healthcare revenue cycle, specifically patient financial engagement and integrated payments, and your seat at RevSpring since the 2024 carve-out from GTCR makes you one of the few people who has actually owned the thesis rather than modeled it. Two things we'd value your read on: whether the TrustCommerce deal reflects real vendor consolidation among health systems or just a procurement preference, and where AI is changing RCM cost-to-collect versus where it's still marketing. Happy to share what we're seeing on the provider side in return. Would 30 minutes in the next couple of weeks work? Best, [Your Name]

Linked companies

Sources